Midgard Science

InnoSer

Diepenbeek, Belgium innoserlaboratories.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

InnoSer is a European preclinical CRO that supports discovery and development programs with in vitro and in vivo research services, non-GLP toxicology, and GLP safety assessment. It works with biotechnology and pharmaceutical clients across therapeutic areas including oncology, immunology, neurology, metabolic disease, cardiovascular disease, nephrology, and toxicology. The company operates from sites in Belgium, the Netherlands, and Germany.

Services

  • Non-GLP Toxicology & Screening Studies

    Designs and runs tailored non-GLP studies to assess dose range, tolerability, translational relevance, and go/no-go decisions before GLP testing.

    ADME, DMPK & toxicology

  • GLP Safety Assessments

    Supports GLP toxicology programs for IND-enabling safety studies, including study design and execution for regulatory submission.

    ADME, DMPK & toxicology

  • IND-Enabling Studies

    Provides nonclinical safety studies and related support for IND submission.

    ADME, DMPK & toxicology

  • Oncology CRO Services

    Offers in vitro and in vivo oncology research services across multiple therapy types and model systems.

  • Immunology CRO Services

    Provides immunology studies spanning in vitro and in vivo models for hypersensitivity, inflammatory, and autoimmune indications.

  • Metabolic disease CRO Services

    Supports preclinical metabolic disease research using mouse and rat models of obesity, diabetes, and related complications.

  • Facility Management

    Provides technical support for biomedical research facilities, including colony support, housing, cryopreservation, and rederivation.

  • Colony Management

    Manages breeding, housing, cryopreservation, rederivation, and long-term colony preservation of mouse models.

2 more services
  • Rodent Behavioral Testing
  • Pathology

Capabilities

Assays and studies
  • Rodent models
  • Toxicology
  • In vivo
  • PK/PD
  • Histopathology
  • mRNA
17 more
  • Small molecules
  • High-content imaging
  • In vitro assays
  • Immunoassays
  • Cell-based assays
  • Organoid high-throughput screening
  • Mechanism-of-action studies
  • Early in vivo proof-of-concept
  • Biomarker analysis
  • Histopathological analysis
  • Dose-response studies
  • PK/PD assessments
  • MTD studies
  • Formulation assessment
  • Flow cytometry
  • MSD
  • ELISA
Scale and capacity
  • 2 sites in Belgium and the Netherlands
  • 2 GxP archives
Therapeutic areas
  • Nephrology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic disease
  • Cardiovascular disease
  • Toxicology
  • Rare disease

Instruments and platforms

  • Flow cytometry
  • Meso Scale Discovery (MSD)
  • ELISA
  • qPCR
  • Western blot
  • IVIS
3 more
  • Ultrasound
  • Echocardiography
  • High-content imaging

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • mRNA
  • Cell therapy
  • Vaccine
Species and models
  • Mouse
  • Rat
  • Human cells
  • Rodent cells
  • Humanized mouse models
  • Syngeneic mouse models
9 more
  • Cell line-derived xenografts (CDX)
  • Patient-derived xenografts (PDX)
  • NOD mouse model
  • Db/db mouse model
  • DIO mouse model
  • EAE mouse model
  • TAC mouse model
  • Angiotensin II-induced hypertension mouse model
  • Diabetic cardiomyopathy rat model

Certifications

As the company states them, with the certificate or registry record where there is one.

  • AAALACSelf-reported

  • GLPSelf-reported

    Scope: GLP toxicology studies and immunotoxicology/immunogenicity assessments

  • GMPSelf-reported

    Scope: in vivo adventitious virus testing and potency testing of recombinant vaccines

  • ISO 9001Self-reported

Company

Type
CRO
Founded
2016

Locations

Office
Featuring 2D cell lines, 3D cultures, and organoids for high-throughput
Sites
  • Leiden, Netherlands
  • Gronau, Germany
Serves
Europe, global

Contacts

Similar labs